A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

von Chari, Ajai, Cho, Hearn J., Dhadwal, Amishi, Morgan, Gillian, La, Lisa, Zarychta, Katarzyna, Catamero, Donna, Florendo, Erika, Stevens, Nadege, Verina, Daniel, Chan, Elaine, Leshchenko, Violetta, Laganà, Alessandro, Perumal, Deepak, Mei, Anna Huo-Chang, Tung, Kaity, Fukui, Jami, Jagannath, Sundar, Parekh, Samir
Veröffentlicht in Blood Adv (2017)